DaBomb Protein Biotech Corp. (6578.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
Peer Comparison
About DaBomb Protein Biotech Corp.
—
DaBomb Protein Biotech Corp. is led by CEO Yu Fen Liu, employs 46 people, headquartered in Tainan, TW, publicly traded since 2016.
DaBomb Protein Biotech Corp. (6578.TWO) stock trades at $17.15 with a market capitalization of $1.17B. The stock is valued at a negative price-to-earnings (P/E) ratio of -28.10, reflecting a net loss over the last twelve months, price-to-book of 1.16, price-to-sales of 3.45. Over the past 52 weeks the stock has ranged between $14.35 and $21.10, and currently trades 18.7% below its 52-week high.
On profitability, DaBomb Protein Biotech Corp. generates a return on equity (ROE) of -4.11% (negative, reflecting a net loss), an operating margin of 9.36%, a net profit margin of -12.35%.
Official website: www.dabombprotein.com
DaBomb Protein Biotech Corp. (6578.TWO) — frequently asked questions
What is DaBomb Protein Biotech Corp. (6578.TWO) stock price today?
DaBomb Protein Biotech Corp. (6578.TWO) is currently trading at $17.15, up 4.26% today.
What is 6578.TWO P/E ratio?
DaBomb Protein Biotech Corp.'s P/E ratio is -28.10. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 6578.TWO return on equity (ROE)?
DaBomb Protein Biotech Corp.'s return on equity (ROE) is -4.11%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is DaBomb Protein Biotech Corp.'s market cap?
DaBomb Protein Biotech Corp. has a market capitalization of $1.17B.
Does 6578.TWO pay a dividend?
DaBomb Protein Biotech Corp. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6578.TWO carry?
DaBomb Protein Biotech Corp. has a debt-to-equity ratio of 0.07. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6578.TWO's profit margin?
DaBomb Protein Biotech Corp. reports a net profit margin of -12.35% — the share of revenue left after every cost, including tax and interest.
What sector is 6578.TWO in?
DaBomb Protein Biotech Corp. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6578.TWO listed on?
DaBomb Protein Biotech Corp. trades on TWO under the ticker 6578.TWO.
What is 6578.TWO's 52-week range?
Over the last year DaBomb Protein Biotech Corp. has traded between $14.35 and $21.10.
Related — Stocks
Popular Stocks
Screens 6578.TWO currently matches
On the figures above, DaBomb Protein Biotech Corp. passes the filters for 6 of our ready-made screens, among them Low Debt Stocks, Small Cap Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.